CClinicalTrials.gg
RecruitingNCT06829940Updated Feb 17, 2025

Efficacy of Baduanjin Exercise in COVID-19 Contraction Patients With Idiopathic Chronic Fatigue

An interventional study of Baduanjin exercise training (BET) in Chronic COVID-19 Syndrome, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2025-02-17.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Feb 2025, 1 year 7 months ago, but the record still lists the study as recruiting.
  • Registered 4 months after the study started (first participant enrolled Oct 2024, registered Feb 2025).
  • Started Oct 2024; still recruiting 1 year 11 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
All
01

Study summary

Post-COVID recovery is associated with reduced functional fitness/capacity, low quality of life, and physical disabilities in those who survived after contracting the disease. The unpleasant symptoms of chronic post-viral/post-COVID syndrome (chronic fatigue perception, variant nonspecific myalgia, bad mood or depression, and insomnia or sleep disturbances) usually magnify the symptoms of already existing previously diagnosed concurrent untreatable chronic disorders , including the idiopathic chronic fatigue (ICF).(Leszczak et al., 2024)

Baduanjin exercise training (BET) is one of the Chinese traditional Health-Qigong exercises that not only integrate slow coordinating postures/positions, breathing techniques, musculoskeletal stretching movements/positions, and meditative mind but also plays a strong role concerning health benefits (e.g. musculoskeletal pain-reducing, sleep disturbance-enhancing effects, and fatigue-reducing effects) (Zou et al., 2018).

Read the detailed description

forty idiopathic chronic fatigue (ICF) patients will be randomly assigned into two equal groups (n=20)

  1. Study group (20 patients) this group will be supervised daily, except Fridays, during the 60-minute session of 12-week BET) or waitlist group
  2. Control group (20 patients)
02

Conditions studied

  • Chronic COVID-19 Syndrome

Browse trials for

03

In context

COVID-19

7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.

This study's planned enrollment of 40 is below the median of 100 across 4,099 interventional studies indexed under COVID-19.

Browse COVID-19 studies →

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

    • 40 patients will be recruited in the study.

      • age ≥ 18 to ≤ 50 years old
      • achieved three diagnostic items/criteria of ICF will be included in this BET trial: Fatigue lasting over 6 months, which significantly limits daily activities, reducing the person's usual activity level by more than 50%, as confirmed by a doctor.

At least three of the following symptoms:

Generalized muscle weakness Difficulty sleeping Frequent headaches A painful throat Muscle tenderness throughout the body Migratory joint pain Swollen lymph nodes in the neck or armpits Fatigue lasting more than a day after typical activities

Exclusion criteria

Exclusion Criteria:

  • Patients with a history of medical or complementary treatments for ICF disorder in the 6 months before contracting COVID or after recovery.
  • Individuals who have engaged in therapeutic exercise, pharmacological treatments, or complementary therapies for post-COVID symptoms within the last six months prior to enrollment.
  • ICF patients regularly using antidepressants or antipsychotics were excluded.
  • Those who take sleeping pills regularly were also excluded.
  • Patients with autoimmune diseases, malignant conditions, anemia, endocrine disorders, systemic diseases, or osteoarthritis affecting the cervical spine, lumbar region, or limbs were excluded.
  • Individuals with abnormal results in laboratory tests, including neurological, neurophysiological, cardiological, liver/kidney function tests, or urine/stool analyses (as determined by a physician) were excluded.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Baduanjin exercise training

    Each BET session consisted of a 10-minute warm-up and a 10-minute cool-down period \[Xia et al., 2023\]. These were followed by a 40-minute BET segment, which typically involved eight distinct body postures. These postures are based on the "Health Qigong Baduanjin Standard," as outlined in Zhao et al. \[2019\] and Koh \[1982\]. The eight postures are: (1) Support the Heaven, (2) Draw a Bow to Each Side, (3) Hold Up a Single Hand, (4) Practice Looking Back, (5) Shake the Hand and Wag the Tail, (6) Touch the Feet with Both Hands, (7) Climbing with Both Hands, and (8) Relax the Back, as explained in Zeng et al. \[2020\]

    Other: Baduanjin exercise training (BET)

  • No intervention
    waitlist

    this group will receive no intervention

Interventions

  • OtherBaduanjin exercise training (BET)

    Baduanjin Exercise Training (BET) is a traditional Chinese exercise focused on improving physical health, flexibility, balance, and mental well-being. It involves a 10-minute warm-up, a 40-minute core session practicing eight distinct postures, and a 10-minute cool-down. The postures, based on the Baduanjin form, target different body parts and promote strength, flexibility, and circulation. The exercises are synchronized with deep breathing to enhance relaxation and stress reduction. BET is especially beneficial for joint health, mobility, and mental clarity, making it suitable for individuals of all ages and fitness levels

06

What researchers measure

Primary outcomes

  1. Pulmonary function: By Spirometry Device:

    • Pulmonary function: By Spirometry Device: it measure ventilatory functions. forced vital capacity (FVC)

    Time frame: By Spirometry Device: forced vital capacity will be measured at baseline, and it will be measured after twelve weeks again

Secondary outcomes

  1. Pulmonary function: By Spirometry Device:

    Pulmonary function: By Spirometry Device: it measure ventilatory functions forced expiratory volume in one second (FEV1)

    Time frame: By Spirometry Device forced expiratory volume in one second (FEV1) will be measured at baseline, and it will be measured after twelve weeks again

  2. Measuring functional capacity: By Six-minute walk test (6MWT)

    Measuring functional capacity: By Six-minute walk test (6MWT): is a self paced submaximal field exercise test , It will be performed according to the standard procedure is administered in a 30 meter hallway. (Launois et al., 2012 and ATS statement2002)

    Time frame: Measuring functional capacity: By Six-minute walk test (6MWT)::will be measured at baseline, and it will be measured again after twelve weeks

  3. Modified Borg dyspnea scale (MBDS)

    Modified Borg dyspnea scale (MBDS) is patient self-reported measures of one's difficulty in breathing upon exertion

    Time frame: Modified Borg dyspnea scale (MBDS) will be measured at baseline, and it will be measured again after twelve weeks

  4. Strength of lower limb muscles By a thirty-second sit-to-stand test

    thirty-second sit-to-stand test was designed for testing leg strength and endurance it is the number of repetitions of sit-to-stand action executed in thirty seconds

    Time frame: thirty-second sit-to-stand test will be measured at baseline, and it will be measured again after twelve weeks

  5. Endurance of upper limb muscles: by the maximal repetitions of push-ups (MRPU).

    Endurance of upper limb muscles: by the maximal repetitions of push-ups (MRPU) is commonly used to assess upper body strength, muscular endurance, and overall fitness levels.

    Time frame: the maximal repetitions of push-ups (MRPU). will be measured at baseline, and it will be measured again after twelve weeks

  6. Cardiorespiratory fitness:by the index of Ruffier test (IRT).

    Cardiorespiratory fitness: by the index of Ruffier test (IRT). is a simple, non-invasive method used to assess the recovery capacity of the heart after exercise and can be used to monitor fitness improvements over time.

    Time frame: Cardiorespiratory fitness:by the index of Ruffier test (IRT). will be measured at baseline, and it will be measured again after twelve weeks

  7. Quality of life: by the short form 36 questionnaire (SF)

    Quality of life: by the short form 36 questionnaire (SF) is a set of generic, coherent, and easily administered quality-of-life measures. These measures rely upon patient self-reporting and have been widely used

    Time frame: Quality of life: by the short form 36 questionnaire (SF) will be measured at baseline, and it will be measured again after twelve weeks

  8. sleep quality by Pittsburgh sleep quality index (PSQI):

    sleep quality by Pittsburgh sleep quality index (PSQI): This is a 19 item widely used self-report questionnaire designed to assess sleep quality and disturbances

    Time frame: sleep quality by Pittsburgh sleep quality index (PSQI):will be measured at baseline, and it will be measured again after twelve weeks

  9. Beck Depression Inventory (BDI):

    Beck Depression Inventory (BDI):widely used self-report questionnaire designed to assess the presence and severity of depressive symptoms

    Time frame: Beck Depression Inventory (BDI):will be measured at baseline, and it will be measured again after twelve weeks

  10. fatigue assessment by Buzhongyiqi-Tang questionnaire (BZTQ):

    Buzhongyiqi-Tang questionnaire (BZTQ): Fatigue syndrome's severity can be rated via this validated 16-item questionnaire (every item was rated 7-Likert scale responses starting from zero to seven).

    Time frame: Buzhongyiqi-Tang questionnaire (BZTQ)::will be measured at baseline, and it will be measured again after twelve weeks

07

Study locations

1 of 1 sites recruiting
  • Cairo University
    Cairo, 11432, Egypt
    • Alaa El-Moatasem, lecturer · Contact · alaamotasem@cu.edu.eg · 01006625054
    • Alaa El-Moatasem, lecturer · Principal investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 17, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06829940
Lead sponsor
Cairo University
Responsible party
Alaa Mohamed El-Moatasem Mohamed (lecturer of physical therapy, Cairo University) — Principal investigator
First posted
Feb 17, 2025
Start date
Oct 9, 2024
Primary completion
Feb 22, 2025 (estimated)
Completion
Mar 1, 2025 (estimated)
Last update
Feb 17, 2025

Study contacts

Alaa El-moatasem, lecturer
Contact
alaamotasem@cu.edu.eg
01006625054
Rania ali, assistant professor
Contact
roni.diamond8@gmail.com
010015931155
Alaa El-moatasem, lecturer
principal investigator · Cairo University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion